Nihon Kohden Corporation (NHNKY) Stock
Nihon Kohden Corporation specializes in the comprehensive lifecycle of medical electronic equipment, from research and development and manufacturing to sales, repair, and ongoing maintenance. The company operates across a global footprint encompassing Japan, the Americas, Europe, and the wider Asian market, as well as other international regions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Nihon Kohden Corporation
Nihon Kohden Corporation specializes in the comprehensive lifecycle of medical electronic equipment, from research and development and manufacturing to sales, repair, and ongoing maintenance. The company operates across a global footprint encompassing Japan, the Americas, Europe, and the wider Asian market, as well as other international regions. Their diverse product portfolio includes advanced physiological measurement devices such as electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram instruments, and polygraphs tailored for catheterization laboratories. These are often complemented by sophisticated diagnostic information systems, along with essential consumables like recording papers, electrodes, and various catheters, supported by comprehensive maintenance services. The company also delivers complete patient monitoring solutions, which encompass central, bedside, and wireless monitors, remote access software, and associated clinical information systems. These systems utilize critical consumables like specialized electrodes and sensors. Furthermore, Nihon Kohden offers a range of therapeutic devices, including life-saving defibrillators (both manual and automated external defibrillators or AEDs), ventilators, pacemakers, anesthesia machines, and cochlear implants. These are supplied with necessary consumables, such as AED pads and batteries, and accompanying support services. Their offerings extend to other specialized medical apparatus, such as hematology and clinical chemistry analyzers, ultrasound diagnostic units, and equipment designed for research purposes. Crucially, these are supported by specific consumables like test reagents, alongside installation and ongoing maintenance services. Beyond its core medical device operations, the corporation also holds interests in insurance brokerage and technology licensing. Established in 1951, the company maintains its headquarters in Tokyo, Japan.
Nihon Kohden Corporation is headquartered in JP.
Nihon Kohden Corporation (NHNKY) stock trades at $9.89 with a market capitalization of $3.16B. The stock is valued at a price-to-earnings (P/E) ratio of 17.52, price-to-book of 1.41, price-to-sales of 1.06. Over the past 52 weeks the stock has ranged between $8.12 and $14.21, and currently trades 30.4% below its 52-week high. It pays a dividend yielding 2.02%.
On profitability, Nihon Kohden Corporation generates a return on equity (ROE) of 8.27%, return on capital employed of 8.28%, an operating margin of 7.29%, a net profit margin of 6.17%.
Official website: www.nihonkohden.com